UNITAID, Cipla Announce Agreement To Lower Cost Of Combination HIV Medication

Devex: Deal slashes drug price of 3 in 1 pill for people living with HIV
“…UNITAID and Indian pharmaceutical company CIPLA have entered into an agreement that allows the latter to slash the prices of its drug, Q-TIB, by 30 percent. This means that a person living with HIV will soon have access to a full month’s worth of the drug for only $1.99…” (Ravelo, 6/8).